Circulation, Vol 82, 376-383, Copyright © 1990 by American Heart Association
DO Williams, EJ Topol, RM Califf, R Roberts, GB Mancini, JM Joelson, SG Ellis and NS Kleiman
Because thrombus formation may contribute to coronary obstruction in
patients with unstable angina pectoris, we performed a pilot investigation
to determine whether thrombolytic therapy can relieve coronary narrowing in
this acute ischemic syndrome. Sixty-seven patients with rest angina and
angiographic evidence of coronary stenosis were randomly assigned to
receive either low-dose intravenous recombinant tissue-type plasminogen
activator (rt-PA) (0.75 mg/kg over 1 hour), high-dose intravenous rt-PA
(0.75 mg/kg over 1 hour; total dose, 100 mg over 6 hours), or intravenous
placebo followed by repeat coronary angiography at 24-48 hours to assess
change in the severity of coronary narrowing. Each patient also received
oral aspirin and intravenous heparin. Mean values of coronary stenosis
severity (percent of diameter reduction) declined to a similar extent in
each group: placebo, 75 +/- 14% to 72 +/- 14% (p = 0.07); low-dose rt-PA,
75 +/- 16% to 71 +/- 18% (p = 0.03), and high-dose rt-PA, 82 +/- 11% to 77
+/- 17% (p = 0.18), with only the low-dose rt-PA group achieving
statistical significance. Resolution of intracoronary filling defects,
increase in antegrade flow grade, or both also occurred equally among the
three groups. There was considerable variation in individual patient
response. Between 29% and 50% of patients within each group demonstrated a
decrease in stenosis severity, whereas 50% to 57% noted either improvement
in antegrade flow or resolution of intracoronary thrombus. There was no
difference in incidence of major bleeding events among the three
groups.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial
Rhode Island Hospital, Brown University, Providence 02903.
This article has been cited by other articles:
![]() |
S. H. Rezkalla and D. R. Holmes Jr Lipid-rich plaque masquerading as a coronary thrombus. Clin. Med. Res., June 1, 2006; 4(2): 119 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. N. Levine, M. N. Ali, and A. I. Schafer Antithrombotic Therapy in Patients With Acute Coronary Syndromes Arch Intern Med, April 9, 2001; 161(7): 937 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Zaacks, P. R. Liebson, J. E. Calvin, J. E. Parrillo, and L. W. Klein Unstable angina and non-Q wave myocardial infarction: does the clinical diagnosis have therapeutic implications? J. Am. Coll. Cardiol., January 1, 1999; 33(1): 107 - 118. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. McCullough, W. W. O'Neill, M. Graham, R. J. Stomel, F. Rogers, S. David, A. Farhat, R. Kazlauskaite, M. Al-Zagoum, and C. L. Grines A prospective randomized trial of triage angiography in acute coronary syndromes ineligible for thrombolytic therapy: Results of the medicine versus angiography in thrombolytic exclusion (MATE) trial J. Am. Coll. Cardiol., September 1, 1998; 32(3): 596 - 605. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.M.A. Hussain, L. Gould, T. Bharathan, M. Angirekula, S. Choubey, and Yu. Karpov Arteriographic Morphology and Intracoronary Thrombus in Patients with Unstable Angina, Non-Q Wave Myocardial Infarction and Stable Angina Pectoris Angiology, March 1, 1995; 46(3): 181 - 189. [Abstract] [PDF] |
||||
![]() |
MILD IMPACT OF TPA ON UNSTABLE ANGINA Journal Watch (General), August 17, 1990; 1990(817): 4 - 4. [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1990 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |